Skip to main content
Premium Trial:

Request an Annual Quote

Kapa Biosystems Licenses SYBR Green, Melting Curve Tech from Idaho Technology

Premium

This article has been updated from a version posted on Dec. 15 to include additional information from Idaho Technologies.

Idaho Technology said this week that Kapa Biosystems has signed a license agreement that covers reagents or methods using SYBR Green I technology and melting curve analysis for real-time PCR.

Kapa Biosystems, based in Woburn, Mass., with an R&D facility in Cape Town, South Africa, uses high-throughput molecular evolution to optimize enzymes for DNA amplification, DNA sequencing, and molecular diagnostic applications. The company offers a range of PCR and qPCR reagents, including Kapa SYBR Fast, KAPA Probe Fast, Kapa HiFi DNA Polymerase, and Kapa2G Robust DNA Polymerase.

The company claims that its engineered DNA polymerases "contain unique amino acid modifications that confer dramatic improvements to the functionality of the enzymes when compared to wild-type polymerases."

Idaho Technology said that the agreement is in line with its "ongoing program to license its broad and valuable intellectual property portfolio in cooperation with Roche Diagnostics."

In September, Idaho Tech and Roche licensed a number of PCR-related technologies to Qiagen [PCR Insider 9/17/09]. Idaho also signed similar licensing agreements with Finnzymes and Thermo Fisher Scientific earlier in the year.

An Idaho Technologies spokesperson said that the company has signed two additional licensing agreements in the past two months that have not yet been disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.